<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00825383</url>
  </required_header>
  <id_info>
    <org_study_id>DF498</org_study_id>
    <nct_id>NCT00825383</nct_id>
  </id_info>
  <brief_title>Effect of Dietary Fiber on Glucose &amp; Lipids in Non Insulin Dependent Diabetes Mellitus (NIDDM)</brief_title>
  <official_title>Effect of Dietary Fiber on Glucose, Lipid, and Mineral Metabolism in Patients With Non Insulin Dependent Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effect of Dietary Fiber on glucose, lipid, and mineral metabolism in patients with non
      insulin dependent diabetes mellitus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two diets will be compared,a low fiber diet and a high fiber diet. These two diets will
      differ only in the content of total dietray fiber derived from natural food products. The
      diets will be identical in terms of total energy, percentage of total energy as proteins, fat
      and carbohydrates.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 1993</start_date>
  <completion_date type="Actual">December 1995</completion_date>
  <primary_completion_date type="Actual">December 1995</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>glucose and lipid metabolism</measure>
    <time_frame>Baseline and during the last 5 days of each 6 week dietary phase</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>calcium isotope absorption in the gastrointestinal tract, stool mineral content, 24 h urinary mineral concentration, and serum chemistry including mineral concentration.</measure>
    <time_frame>Baseline and during the last 5 days of each 6 week dietary phase</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Non-Insulin-Dependent Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High Fiber Diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Moderate Fiber Diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Fiber and Moderate Fiber Diets</intervention_name>
    <description>Dietary</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>Dietary Fiber Study</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  NIDDM

          -  age 35 to 80 years

          -  stable oral hypoglycemic treatment for at least one month

          -  fasting triglycerides &lt; 500 mg/dl

        Exclusion Criteria:

          -  insulin dependent NIDDM

          -  insulin dependent diabetes

          -  hepatic disease

          -  significant hepatic dysfunction

          -  signifiacnt renal dysfunction

          -  presence of significant hematological, neurological, cardiovascular or
             gastrointestinal disorder, unless stable for past 6 months,

          -  serious intercurrent illness or anticipated major surgery

          -  female pregnant or likely to become pregnant

          -  chronic drug abuse, alcoholism or psychaitric disorder within the past 2 years

          -  treated with beta adrenergic blockers

          -  on lipid lowering drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abhimanyu Garg</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern Medical Center at Dallas</affiliation>
  </overall_official>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2009</study_first_submitted>
  <study_first_submitted_qc>January 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2009</study_first_posted>
  <last_update_submitted>June 19, 2013</last_update_submitted>
  <last_update_submitted_qc>June 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Abhimanyu Garg</investigator_full_name>
    <investigator_title>Professor, Chairman Division Nutrition &amp; Metabolic Diseases</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>lipids</keyword>
  <keyword>fiber</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

